Jacobs Levy Equity Management
WVE icon

Jacobs Levy Equity Management’s Wave Life Sciences WVE Stock Holding History

Jacobs Levy Equity Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-338,546
Closed -$5.76M – 1073
2025
Q4 		$5.76M Buy
+338,546
New +$3.44M 0.02% 377
2024
Q4 		– Sell
-104,526
Closed -$857K – 1055
2024
Q3 		$857K Sell
104,526
-262,075
-71% -$1.57M ﹤0.01% 752
2024
Q2 		$1.83M Buy
366,601
+124,741
+52% +$712K 0.01% 617
2024
Q1 		$1.49M Buy
241,860
+29,483
+14% +$148K 0.01% 642
2023
Q4 		$1.07M Buy
+212,377
New +$1.14M 0.01% 704
2022
Q2 		– Sell
-423,365
Closed -$847K – 1102
2022
Q1 		$847K Sell
423,365
-61,161
-13% -$150K 0.01% 784
2021
Q4 		$1.52M Buy
484,526
+91,962
+23% +$382K 0.01% 669
2021
Q3 		$1.92M Buy
392,564
+360,668
+1,131% +$2.19M 0.01% 619
2021
Q2 		$212K Sell
31,896
-68,478
-68% -$447K ﹤0.01% 979
2021
Q1 		$563K Sell
100,374
-357,581
-78% -$3.44M ﹤0.01% 845
2020
Q4 		$3.6M Buy
457,955
+4,788
+1% +$40.2K 0.03% 458
2020
Q3 		$3.85M Buy
453,167
+75,775
+20% +$831K 0.04% 399
2020
Q2 		$3.93M Buy
377,392
+365,416
+3,051% +$3.44M 0.04% 391
2020
Q1 		$112K Buy
+11,976
New +$102K ﹤0.01% 952

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
GP
GSK plc London $602M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Jacobs Levy Equity Management's WVE Position: Q1 2026 in Review

Jacobs Levy Equity Management sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 338,546 shares — an estimated $5.76M sold.

Jacobs Levy Equity Management first reported a position in WVE in Q1 2020 and held it in 14 quarters. The position peaked at $5.76M in Q4 2025. 232 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Jacobs Levy Equity Management reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 338,546 Wave Life Sciences shares in Q1 2026, an estimated $5.76M.
  • Jacobs Levy Equity Management first reported a position in Wave Life Sciences in Q1 2020 and held it in 14 quarters.
  • Jacobs Levy Equity Management's Wave Life Sciences position peaked at $5.76M in Q4 2025.
  • 232 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.